{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:43:47Z","timestamp":1781829827469,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T00:00:00Z","timestamp":1700870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T00:00:00Z","timestamp":1700870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This work was sponsored by the Science and Technology Bureau of Yuzhong District, Chongqing","award":["20200144"],"award-info":[{"award-number":["20200144"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Thyroid cancer is one of the most frequently reported endocrine system malignancies. It is difficult to distinguish follicular thyroid cancer (FTC) from follicular thyroid adenoma (FTA) during pathological diagnosis in patients without lymph nodes or distant metastases. Therefore, we conducted a retrospective study to investigate the significance of SLC5A8 methylation and expression in the diagnosis and prognosis of FTC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We used 165 tissue samples, including FTC (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200958), thyroid tumors of uncertain malignant potential (TT-UMP,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200940), and FTA (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200967), to explore the differences in SLC5A8 methylation and mRNA transcription in different pathological types. Survival analysis was conducted to evaluate the recurrence rate at a 5-year follow-up.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The SLC5A8 methylation positive rate was higher in patients with thyroglobulin\u2009\u2265\u200940\u00a0\u03bcg\/l and Chol\u2009\u2265\u20095.17\u00a0mmol\/l, and it was higher in patients with FTC (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200942, 72.4%) than those with FTA (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200927, 40.3%) and TT-UMP (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200923, 57.5%). The relative concentration of SLC5A8 mRNA was lower in patients with FTC than in those with FTA (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). At 5-year follow-ups, patients who were SLC5A8 methylation-positive had a higher recurrence rate than those who were methylation-negative.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our current study indicates that SLC5A8 gene methylation occurs more commonly in patients with FTC than in those with FTA. The differences in SLC5A8 methylation and expression among FTA, FTC, and TT-UMP provide an important basis for further exploration of epigenetic changes in the occurrence, development, and prognosis of thyroid cancer. Our findings need to be further validated in larger populations with long-term follow-up in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-023-03240-1","type":"journal-article","created":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T01:01:27Z","timestamp":1700874087000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Role of hypermethylated SLC5A8 in follicular thyroid cancer diagnosis and prognosis prediction"],"prefix":"10.1186","volume":"21","author":[{"given":"Yan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenjin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,25]]},"reference":[{"key":"3240_CR1","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","volume":"30","author":"S Filetti","year":"2019","unstructured":"Filetti S, Durante C, Hartl D, Leboulleux S, Locati LD, Newbold K, Papotti MG, Berruti A, clinicalguidelines@esmo.org. EGCEa: thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-updagger. Ann Oncol. 2019;30:1856\u201383.","journal-title":"Ann Oncol"},{"key":"3240_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ecl.2018.10.002","volume":"48","author":"CD Seib","year":"2019","unstructured":"Seib CD, Sosa JA. Evolving understanding of the epidemiology of thyroid cancer. Endocrinol Metab Clin North Am. 2019;48:23\u201335.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"3240_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ecl.2018.10.001","volume":"48","author":"SL Asa","year":"2019","unstructured":"Asa SL. The current histologic classification of thyroid cancer. Endocrinol Metab Clin North Am. 2019;48:1\u201322.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"3240_CR4","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2217\/fon-2017-0024","volume":"13","author":"DVP Araque","year":"2017","unstructured":"Araque DVP, Bleyer A, Brito JP. Thyroid cancer in adolescents and young adults. Future Oncol. 2017;13:1253\u201361.","journal-title":"Future Oncol"},{"key":"3240_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S2213-8587(17)30325-X","volume":"6","author":"G Grani","year":"2018","unstructured":"Grani G, Lamartina L, Durante C, Filetti S, Cooper DS. Follicular thyroid cancer and Hurthle cell carcinoma: challenges in diagnosis, treatment, and clinical management. Lancet Diabetes Endocrinol. 2018;6:500\u201314.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3240_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s12094-016-1554-5","volume":"19","author":"J Capdevila","year":"2017","unstructured":"Capdevila J, Galofre JC, Grande E, Zafon Llopis C, Ramon YCAT, Navarro Gonzalez E, Jimenez-Fonseca P, Santamaria Sandi J, Gomez Saez JM, Riesco Eizaguirre G. Consensus on the management of advanced radioactive iodine-refractory differentiated thyroid cancer on behalf of the Spanish Society of Endocrinology Thyroid Cancer Working Group (GTSEEN) and Spanish Rare Cancer Working Group (GETHI). Clin Transl Oncol. 2017;19:279\u201387.","journal-title":"Clin Transl Oncol"},{"key":"3240_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.semcancer.2020.06.013","volume":"79","author":"P Fallahi","year":"2022","unstructured":"Fallahi P, Ferrari SM, Elia G, Ragusa F, Patrizio A, Paparo SR, Marone G, Galdiero MR, Guglielmi G, Foddis R, et al. Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin. Semin Cancer Biol. 2022;79:203\u201316.","journal-title":"Semin Cancer Biol"},{"key":"3240_CR8","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3390\/ijerph17041373","volume":"17","author":"MA Hossain","year":"2020","unstructured":"Hossain MA, Asa TA, Rahman MM, Uddin S, Moustafa AA, Quinn JMW, Moni MA. Network-based genetic profiling reveals cellular pathway differences between follicular thyroid carcinoma and follicular thyroid adenoma. Int J Environ Res Public Health. 2020;17:1373.","journal-title":"Int J Environ Res Public Health"},{"key":"3240_CR9","first-page":"11236","volume":"8","author":"L Zhao","year":"2015","unstructured":"Zhao L, Zhu XY, Jiang R, Xu M, Wang N, Chen GG, Liu ZM. Role of GPER1, EGFR and CXCR1 in differentiating between malignant follicular thyroid carcinoma and benign follicular thyroid adenoma. Int J Clin Exp Pathol. 2015;8:11236\u201347.","journal-title":"Int J Clin Exp Pathol"},{"key":"3240_CR10","first-page":"1523","volume":"31","author":"MP Gronlund","year":"2021","unstructured":"Gronlund MP, Jensen JS, Hahn CH, Gronhoj C, Buchwald CV. Risk factors for recurrence of follicular thyroid cancer: a systematic review. Thyroid. 2021;31:1523\u201330.","journal-title":"Thyroid"},{"key":"3240_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1755-8794-6-38","volume":"6","author":"A Pfeifer","year":"2013","unstructured":"Pfeifer A, Wojtas B, Oczko-Wojciechowska M, Kukulska A, Czarniecka A, Eszlinger M, Musholt T, Stokowy T, Swierniak M, Stobiecka E, et al. Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues. BMC Med Genomics. 2013;6:38.","journal-title":"BMC Med Genomics"},{"key":"3240_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cancergencyto.2009.09.004","volume":"196","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Bao YL, Wu Y, Yu CL, Sun Y, Li YX. Identification and characterization of the human SLC5A8 gene promoter. Cancer Genet Cytogenet. 2010;196:124\u201332.","journal-title":"Cancer Genet Cytogenet"},{"key":"3240_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2220\/biomedres.27.243","volume":"27","author":"T Iwanaga","year":"2006","unstructured":"Iwanaga T, Takebe K, Kato I, Karaki S, Kuwahara A. Cellular expression of monocarboxylate transporters (MCT) in the digestive tract of the mouse, rat, and humans, with special reference to slc5a8. Biomed Res. 2006;27:243\u201354.","journal-title":"Biomed Res"},{"key":"3240_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1471-4159.2006.03878.x","volume":"98","author":"PM Martin","year":"2006","unstructured":"Martin PM, Gopal E, Ananth S, Zhuang L, Itagaki S, Prasad BM, Smith SB, Prasad PD, Ganapathy V. Identity of SMCT1 (SLC5A8) as a neuron-specific Na+-coupled transporter for active uptake of L-lactate and ketone bodies in the brain. J Neurochem. 2006;98:279\u201388.","journal-title":"J Neurochem"},{"key":"3240_CR15","doi-asserted-by":"publisher","first-page":"8412","DOI":"10.1073\/pnas.1430846100","volume":"100","author":"H Li","year":"2003","unstructured":"Li H, Myeroff L, Smiraglia D, Romero MF, Pretlow TP, Kasturi L, Lutterbaugh J, Rerko RM, Casey G, Issa JP, et al. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Proc Natl Acad Sci U S A. 2003;100:8412\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3240_CR16","first-page":"4679","volume":"24","author":"XM Zhang","year":"2020","unstructured":"Zhang XM, Meng QH, Kong FF, Wang K, Du LJ. SLC5A8 regulates the biological behaviors of cervical cancer cells through mediating the Wnt signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24:4679\u201386.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3240_CR17","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1128\/MCB.01702-12","volume":"33","author":"S Elangovan","year":"2013","unstructured":"Elangovan S, Pathania R, Ramachandran S, Ananth S, Padia RN, Srinivas SR, Babu E, Hawthorn L, Schoenlein PV, Boettger T, et al. Molecular mechanism of SLC5A8 inactivation in breast cancer. Mol Cell Biol. 2013;33:3920\u201335.","journal-title":"Mol Cell Biol"},{"key":"3240_CR18","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.biopha.2013.06.007","volume":"67","author":"M Zane","year":"2013","unstructured":"Zane M, Agostini M, Enzo MV, Casal Ide E, Del Bianco P, Torresan F, Merante Boschin I, Pennelli G, Saccani A, Rubello D, et al. Circulating cell-free DNA, SLC5A8 and SLC26A4 hypermethylation, BRAF(V600E): a non-invasive tool panel for early detection of thyroid cancer. Biomed Pharmacother. 2013;67:723\u201330.","journal-title":"Biomed Pharmacother"},{"key":"3240_CR19","doi-asserted-by":"publisher","first-page":"6954","DOI":"10.1002\/jcp.29591","volume":"235","author":"F Khatami","year":"2020","unstructured":"Khatami F, Larijani B, Heshmat R, Nasiri S, Haddadi-Aghdam M, Teimoori-Toolabi L, Tavangar SM. Hypermethylated RASSF1 and SLC5A8 promoters alongside BRAF(V600E) mutation as biomarkers for papillary thyroid carcinoma. J Cell Physiol. 2020;235:6954\u201368.","journal-title":"J Cell Physiol"},{"key":"3240_CR20","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.prp.2014.12.005","volume":"211","author":"A Nechifor-Boila","year":"2015","unstructured":"Nechifor-Boila A, Borda A, Sassolas G, Hafdi-Nejjari Z, Catana R, Borson-Chazot F, Berger N, Decaussin-Petrucci M. Thyroid tumors of uncertain malignant potential: morphologic and imunohistochemical analysis of 29 cases. Pathol Res Pract. 2015;211:320\u20135.","journal-title":"Pathol Res Pract"},{"key":"3240_CR21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1210\/clinem\/dgaa950","volume":"106","author":"H Zhang","year":"2021","unstructured":"Zhang H, Zhang Z, Liu X, Duan H, Xiang T, He Q, Su Z, Wu H, Liang Z. DNA methylation haplotype block markers efficiently discriminate follicular thyroid carcinoma from follicular adenoma. J Clin Endocrinol Metab. 2021;106:1011\u201321.","journal-title":"J Clin Endocrinol Metab"},{"key":"3240_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13000-019-0817-1","volume":"14","author":"H Duan","year":"2019","unstructured":"Duan H, Liu X, Ren X, Zhang H, Wu H, Liang Z. Mutation profiles of follicular thyroid tumors by targeted sequencing. Diagn Pathol. 2019;14:39.","journal-title":"Diagn Pathol"},{"key":"3240_CR23","doi-asserted-by":"publisher","first-page":"26769","DOI":"10.1074\/jbc.C600189200","volume":"281","author":"M Thangaraju","year":"2006","unstructured":"Thangaraju M, Ananth S, Martin PM, Roon P, Smith SB, Sterneck E, Prasad PD, Ganapathy V. c\/ebpdelta Null mouse as a model for the double knock-out of slc5a8 and slc5a12 in kidney. J Biol Chem. 2006;281:26769\u201373.","journal-title":"J Biol Chem"},{"key":"3240_CR24","doi-asserted-by":"publisher","first-page":"44522","DOI":"10.1074\/jbc.M405365200","volume":"279","author":"E Gopal","year":"2004","unstructured":"Gopal E, Fei YJ, Sugawara M, Miyauchi S, Zhuang L, Martin P, Smith SB, Prasad PD, Ganapathy V. Expression of slc5a8 in kidney and its role in Na(+)-coupled transport of lactate. J Biol Chem. 2004;279:44522\u201332.","journal-title":"J Biol Chem"},{"key":"3240_CR25","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3389\/fphys.2020.00561","volume":"11","author":"S Huang","year":"2020","unstructured":"Huang S, Wu Z, Yuan X, Li N, Li T, Wang J, Levesque CL, Feng C. Transcriptome differences suggest novel mechanisms for intrauterine growth restriction mediated dysfunction in small intestine of neonatal piglets. Front Physiol. 2020;11:561.","journal-title":"Front Physiol"},{"key":"3240_CR26","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.jtho.2020.05.002","volume":"15","author":"MP Smeltzer","year":"2020","unstructured":"Smeltzer MP, Wynes MW, Lantuejoul S, Soo R, Ramalingam SS, Varella-Garcia M, Meadows Taylor M, Richeimer K, Wood K, Howell KE, et al. The international association for the study of lung cancer global survey on molecular testing in lung cancer. J Thorac Oncol. 2020;15:1434\u201348.","journal-title":"J Thorac Oncol"},{"key":"3240_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.lungcan.2012.11.019","volume":"79","author":"JY Park","year":"2013","unstructured":"Park JY, Kim D, Yang M, Park HY, Lee SH, Rincon M, Kreahling J, Plass C, Smiraglia DJ, Tockman MS, Kim SJ. Gene silencing of SLC5A8 identified by genome-wide methylation profiling in lung cancer. Lung Cancer. 2013;79:198\u2013204.","journal-title":"Lung Cancer"},{"key":"3240_CR28","first-page":"1","volume":"4","author":"JK Stephen","year":"2015","unstructured":"Stephen JK, Chen KM, Merritt J, Chitale D, Divine G, Worsham MJ. Methylation markers for early detection and differentiation of follicular thyroid cancer subtypes. Cancer Clin Oncol. 2015;4:1\u201312.","journal-title":"Cancer Clin Oncol"},{"key":"3240_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fcimb.2016.00121","volume":"6","author":"A Orellana-Manzano","year":"2016","unstructured":"Orellana-Manzano A, O\u2019Ryan MG, Lagomarcino AJ, George S, Munoz MS, Mamani N, Serrano CA, Harris PR, Ramilo O, Mejias A, et al. Helicobacter pylori infection is associated with decreased expression of SLC5A8, a cancer suppressor gene, in young children. Front Cell Infect Microbiol. 2016;6:121.","journal-title":"Front Cell Infect Microbiol"},{"key":"3240_CR30","doi-asserted-by":"publisher","first-page":"13445","DOI":"10.1007\/s13277-016-5170-3","volume":"37","author":"BS Hu","year":"2016","unstructured":"Hu BS, Xiong SM, Li G, Li JP. Downregulation of SLC5A8 inhibits hepatocellular carcinoma progression through regulation of Wnt\/beta-catenin signaling. Tumour Biol. 2016;37:13445\u201353.","journal-title":"Tumour Biol"},{"key":"3240_CR31","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00109-013-1088-z","volume":"91","author":"MT Gyparaki","year":"2013","unstructured":"Gyparaki MT, Basdra EK. AG P: DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer. J Mol Med. 2013;91:1249\u201356.","journal-title":"J Mol Med"},{"key":"3240_CR32","doi-asserted-by":"publisher","first-page":"107327482098851","DOI":"10.1177\/1073274820988519","volume":"28","author":"ZH Wu","year":"2021","unstructured":"Wu ZH, Tang Y, Zhou Y. DNA methylation based molecular subtypes predict prognosis in breast cancer patients. Cancer Control. 2021;28:1073274820988519.","journal-title":"Cancer Control"},{"key":"3240_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13148-021-01090-w","volume":"13","author":"X Yin","year":"2021","unstructured":"Yin X, Kong L, Liu P. Identification of prognosis-related molecular subgroups based on DNA methylation in pancreatic cancer. Clin Epigenetics. 2021;13:109.","journal-title":"Clin Epigenetics"},{"key":"3240_CR34","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1210\/jc.2017-00881","volume":"102","author":"M Bisarro Dos Reis","year":"2017","unstructured":"Bisarro Dos Reis M, Barros-Filho MC, Marchi FA, Beltrami CM, Kuasne H, Pinto CAL, Ambatipudi S, Herceg Z, Kowalski LP, Rogatto SR. Prognostic classifier based on genome-wide DNA methylation profiling in well-differentiated thyroid tumors. J Clin Endocrinol Metab. 2017;102:4089\u201399.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-03240-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-023-03240-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-03240-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T01:01:46Z","timestamp":1700874106000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-023-03240-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,25]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3240"],"URL":"https:\/\/doi.org\/10.1186\/s12957-023-03240-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3366467\/v1","asserted-by":"object"}]},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,25]]},"assertion":[{"value":"18 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted following the Declaration of Helsinki (as revised in 2013). The research ethics committee of Chongqing University Central Hospital reviewed and approved the study protocols (IRB2018032).The Research Ethics Committee of Chongqing University Central Hospital reviewed and approved the study protocols (IRB2018032). All participants provided written informed consent prior to inclusion, and all procedures were performed in accordance with the 2013 revised Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All subjects provided written informed consent before their inclusion.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"367"}}